Literature DB >> 3768197

Histomorphometric analysis of a calcaneal stress fracture: a possible complication of fluoride therapy for osteoporosis.

C M Schnitzler, L Solomon.   

Abstract

Pain and swelling of the large joints of the lower limbs occur in about 33% of patients receiving sodium fluoride, calcium, and vitamin D therapy. In a previous study we described radiographic and scintigraphic features suggesting that these symptoms are due to juxtaarticular stress fractures. We now report the histologic features of one such lesion in a calcaneum of a patient receiving fluoride, calcium, and 1 alpha-vitamin D therapy for postmenopausal osteoporosis. Bone biopsy after tetracycline double labeling showed a trabecular fissure fracture and large intratrabecular resorption cavities surrounded by microcallus. Comparison of the static and dynamic histomorphometric parameters in the calcaneum with those in the simultaneously taken iliac bone biopsy showed a marked regional acceleratory phenomenon in the calcaneum that we ascribe to the microfractures. It cannot be said with certainty whether the microfractures resulted from the osteoporosis, the vitamin D, or the sodium fluoride therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768197     DOI: 10.1016/8756-3282(86)90017-7

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

Review 1.  Drug-induced rheumatic disorders: incidence, prevention and management.

Authors:  P Vergne; P Bertin; C Bonnet; C Scotto; R Trèves
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

2.  Serum fluoride and serum osteocalcin levels in response to a novel sustained-release monofluorophosphate preparation: comparison with plain monofluorophosphate.

Authors:  A Battmann; H Resch; C R Libanati; D Ludy; M Fischer; S Farley; D J Baylink
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 3.  Vital biomechanics: proposed general concepts for skeletal adaptations to mechanical usage.

Authors:  H M Frost
Journal:  Calcif Tissue Int       Date:  1988-03       Impact factor: 4.333

4.  The fluoridation of drinking water and hip fracture hospitalization rates in two Canadian communities.

Authors:  M E Suarez-Almazor; G Flowerdew; L D Saunders; C L Soskolne; A S Russell
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

5.  Pharmacokinetic profile of a new fluoride preparation: sustained-release monofluorophosphate.

Authors:  H Resch; C Libanati; J Talbot; M Tabuenca; S Farley; P Bettica; W Tritthart; D Baylink
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

6.  A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis.

Authors:  M Kleerekoper; E L Peterson; D A Nelson; E Phillips; M A Schork; B C Tilley; A M Parfitt
Journal:  Osteoporos Int       Date:  1991-06       Impact factor: 4.507

Review 7.  Drug-induced disorders of bone metabolism. Incidence, management and avoidance.

Authors:  G Jones; P N Sambrook
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.